Maze Therapeutics, Inc. - Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 11/08/2026 | Mar 2026Filed 11/08/2026 | Sep 2025Filed 06/11/2025 | Jun 2025Filed 11/08/2026 | Mar 2025Filed 11/08/2026 | Sep 2024Filed 06/11/2025 | Jun 2024Filed 06/11/2025 | Mar 2024Filed 06/11/2025 |
|---|---|---|---|---|---|---|---|---|
| — | $20 | — | $0 | — | $2.5 | $165 | — | |
| −$45 | −$24 | −$30 | −$34 | −$33 | −$25 | $139 | −$32 | |
| −$0.76 | −$0.45 | −$0.66 | −$0.77 | −$1.15 | −$10.25 | $3.22 | −$13.91 | |
| 59 | 54 | 46 | 44 | 29 | 2.4 | 4.3 | 2.3 |
Trend